Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation

Ian R A Mackenzie, Olaf Ansorge, Michael Strong, Juan Bilbao, Lorne Zinman, Lee Cyn Ang, Matt Baker, Heather Stewart, Andrew Eisen, Rosa V Rademakers, Manuela Neumann

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Mutations in the gene encoding the fused in sarcoma (FUS) protein are responsible for ∼3% of familial amyotrophic lateral sclerosis (ALS) and <1% of sporadic ALS (ALS-FUS). Descriptions of the associated neuropathology are few and largely restricted to individual case reports. To better define the neuropathology associated with FUS mutations, we have undertaken a detailed comparative analysis of six cases of ALS-FUS that include sporadic and familial cases, with both juvenile and adult onset, and with four different FUS mutations. We found significant pathological heterogeneity among our cases, with two distinct patterns that correlated with the disease severity and the specific mutation. Frequent basophilic inclusions and round FUS-immunoreactive (FUS-ir) neuronal cytoplasmic inclusions (NCI) were a consistent feature of our early-onset cases, including two with the p.P525L mutation. In contrast, our late-onset cases that included two with the p.R521C mutation had tangle-like NCI and numerous FUS-ir glial cytoplasmic inclusions. Double-labeling experiments demonstrated that many of the glial inclusions were in oligodendrocytes. Comparison with the neuropathology of cases of frontotemporal lobar degeneration with FUS-ir pathology showed significant differences and suggests that FUS mutations are associated with a distinct pathobiology.

Original languageEnglish (US)
Pages (from-to)87-98
Number of pages12
JournalActa Neuropathologica
Volume122
Issue number1
DOIs
StatePublished - Jul 2011

Fingerprint

Amyotrophic Lateral Sclerosis
Sarcoma
Mutation
Inclusion Bodies
Neuroglia
Frontotemporal Lobar Degeneration
Oligodendroglia
Pathology

Keywords

  • Amyotrophic lateral sclerosis (ALS)
  • Basophilic inclusions
  • Fused in sarcoma (FUS)

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Cellular and Molecular Neuroscience

Cite this

Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations : Two distinct patterns correlating with disease severity and mutation. / Mackenzie, Ian R A; Ansorge, Olaf; Strong, Michael; Bilbao, Juan; Zinman, Lorne; Ang, Lee Cyn; Baker, Matt; Stewart, Heather; Eisen, Andrew; Rademakers, Rosa V; Neumann, Manuela.

In: Acta Neuropathologica, Vol. 122, No. 1, 07.2011, p. 87-98.

Research output: Contribution to journalArticle

Mackenzie, IRA, Ansorge, O, Strong, M, Bilbao, J, Zinman, L, Ang, LC, Baker, M, Stewart, H, Eisen, A, Rademakers, RV & Neumann, M 2011, 'Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation', Acta Neuropathologica, vol. 122, no. 1, pp. 87-98. https://doi.org/10.1007/s00401-011-0838-7
Mackenzie, Ian R A ; Ansorge, Olaf ; Strong, Michael ; Bilbao, Juan ; Zinman, Lorne ; Ang, Lee Cyn ; Baker, Matt ; Stewart, Heather ; Eisen, Andrew ; Rademakers, Rosa V ; Neumann, Manuela. / Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations : Two distinct patterns correlating with disease severity and mutation. In: Acta Neuropathologica. 2011 ; Vol. 122, No. 1. pp. 87-98.
@article{9b96c61263c44d66b5918dc8c0f8972a,
title = "Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: Two distinct patterns correlating with disease severity and mutation",
abstract = "Mutations in the gene encoding the fused in sarcoma (FUS) protein are responsible for ∼3{\%} of familial amyotrophic lateral sclerosis (ALS) and <1{\%} of sporadic ALS (ALS-FUS). Descriptions of the associated neuropathology are few and largely restricted to individual case reports. To better define the neuropathology associated with FUS mutations, we have undertaken a detailed comparative analysis of six cases of ALS-FUS that include sporadic and familial cases, with both juvenile and adult onset, and with four different FUS mutations. We found significant pathological heterogeneity among our cases, with two distinct patterns that correlated with the disease severity and the specific mutation. Frequent basophilic inclusions and round FUS-immunoreactive (FUS-ir) neuronal cytoplasmic inclusions (NCI) were a consistent feature of our early-onset cases, including two with the p.P525L mutation. In contrast, our late-onset cases that included two with the p.R521C mutation had tangle-like NCI and numerous FUS-ir glial cytoplasmic inclusions. Double-labeling experiments demonstrated that many of the glial inclusions were in oligodendrocytes. Comparison with the neuropathology of cases of frontotemporal lobar degeneration with FUS-ir pathology showed significant differences and suggests that FUS mutations are associated with a distinct pathobiology.",
keywords = "Amyotrophic lateral sclerosis (ALS), Basophilic inclusions, Fused in sarcoma (FUS)",
author = "Mackenzie, {Ian R A} and Olaf Ansorge and Michael Strong and Juan Bilbao and Lorne Zinman and Ang, {Lee Cyn} and Matt Baker and Heather Stewart and Andrew Eisen and Rademakers, {Rosa V} and Manuela Neumann",
year = "2011",
month = "7",
doi = "10.1007/s00401-011-0838-7",
language = "English (US)",
volume = "122",
pages = "87--98",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations

T2 - Two distinct patterns correlating with disease severity and mutation

AU - Mackenzie, Ian R A

AU - Ansorge, Olaf

AU - Strong, Michael

AU - Bilbao, Juan

AU - Zinman, Lorne

AU - Ang, Lee Cyn

AU - Baker, Matt

AU - Stewart, Heather

AU - Eisen, Andrew

AU - Rademakers, Rosa V

AU - Neumann, Manuela

PY - 2011/7

Y1 - 2011/7

N2 - Mutations in the gene encoding the fused in sarcoma (FUS) protein are responsible for ∼3% of familial amyotrophic lateral sclerosis (ALS) and <1% of sporadic ALS (ALS-FUS). Descriptions of the associated neuropathology are few and largely restricted to individual case reports. To better define the neuropathology associated with FUS mutations, we have undertaken a detailed comparative analysis of six cases of ALS-FUS that include sporadic and familial cases, with both juvenile and adult onset, and with four different FUS mutations. We found significant pathological heterogeneity among our cases, with two distinct patterns that correlated with the disease severity and the specific mutation. Frequent basophilic inclusions and round FUS-immunoreactive (FUS-ir) neuronal cytoplasmic inclusions (NCI) were a consistent feature of our early-onset cases, including two with the p.P525L mutation. In contrast, our late-onset cases that included two with the p.R521C mutation had tangle-like NCI and numerous FUS-ir glial cytoplasmic inclusions. Double-labeling experiments demonstrated that many of the glial inclusions were in oligodendrocytes. Comparison with the neuropathology of cases of frontotemporal lobar degeneration with FUS-ir pathology showed significant differences and suggests that FUS mutations are associated with a distinct pathobiology.

AB - Mutations in the gene encoding the fused in sarcoma (FUS) protein are responsible for ∼3% of familial amyotrophic lateral sclerosis (ALS) and <1% of sporadic ALS (ALS-FUS). Descriptions of the associated neuropathology are few and largely restricted to individual case reports. To better define the neuropathology associated with FUS mutations, we have undertaken a detailed comparative analysis of six cases of ALS-FUS that include sporadic and familial cases, with both juvenile and adult onset, and with four different FUS mutations. We found significant pathological heterogeneity among our cases, with two distinct patterns that correlated with the disease severity and the specific mutation. Frequent basophilic inclusions and round FUS-immunoreactive (FUS-ir) neuronal cytoplasmic inclusions (NCI) were a consistent feature of our early-onset cases, including two with the p.P525L mutation. In contrast, our late-onset cases that included two with the p.R521C mutation had tangle-like NCI and numerous FUS-ir glial cytoplasmic inclusions. Double-labeling experiments demonstrated that many of the glial inclusions were in oligodendrocytes. Comparison with the neuropathology of cases of frontotemporal lobar degeneration with FUS-ir pathology showed significant differences and suggests that FUS mutations are associated with a distinct pathobiology.

KW - Amyotrophic lateral sclerosis (ALS)

KW - Basophilic inclusions

KW - Fused in sarcoma (FUS)

UR - http://www.scopus.com/inward/record.url?scp=79959615773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959615773&partnerID=8YFLogxK

U2 - 10.1007/s00401-011-0838-7

DO - 10.1007/s00401-011-0838-7

M3 - Article

C2 - 21604077

AN - SCOPUS:79959615773

VL - 122

SP - 87

EP - 98

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 1

ER -